(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ELORA.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ELORA.

ST13

US500000079395224

Class

10

Filing

79395224

Registration

7895116

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

04/03/2026

Trademark type

Combined

Nice classes

10

Filing date

04/04/2024

Registration date

08/19/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/19/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

AU

Examiner

BLAKESLEE, RICHARD A

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording "ELORA." in stylized font.

Holders and representatives

Holders

OncoRes Medical Pty Ltd

Representatives

Thomas M. Joseph OGC Law, LLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Tissue sampling devices for medical usemedical specimen containers for breast tissue; medical apparatus and instruments for use in breast cancer diagnostic surgery and breast cancer tumor removal surgery procedures; medical probes; probes for medical purposes; medical testing apparatusintraoperative imaging technology devices for use in breast cancer surgery; medical diagnostic apparatus for diagnosing breast cancer; medical imaging apparatus; medical diagnostic testing apparatus for diagnosing breast cancer; test probes for medical use; testing probes for medical diagnostic purposes; testing probes for medical purposes; apparatus for medical useoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical analysisoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnosisoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnostic purposesoptical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; medical apparatus for diagnostic purposesapparatus for performing optical coherence tomography and micro-elastography for mapping and for identifying breast cancer; diagnostic apparatus for medical purposeshandheld combination optical coherence tomography and micro-elastography probe; diagnostic imaging apparatus for medical usean optical coherence tomography and micro-elastography apparatus for mapping and for identifying breast cancer; medical probes connected to micro-processing apparatus for medical diagnosis; apparatus for analyzing images for medical usean optical coherence tomography and micro-elastography imaging apparatus; apparatus for medical image formationnamely an optical coherence tomography and micro-elastography imaging device

Publications

History of USPTO decisions and trademark events.

40 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/19/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/28/2026

FIMP

FINAL DISPOSITION PROCESSED

02/28/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/19/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/11/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/24/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/08/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/08/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/04/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/19/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/19/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/01/2025

PUBO

PUBLISHED FOR OPPOSITION

07/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/28/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/05/2025

GNFR

FINAL REFUSAL E-MAILED

05/05/2025

CNFR

FINAL REFUSAL WRITTEN

05/05/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/02/2025

ATRV

ATTORNEY REVIEW COMPLETED

04/30/2025

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

01/24/2025

RFNT

REFUSAL PROCESSED BY IB

11/23/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/04/2024

RFRR

REFUSAL PROCESSED BY MPU

11/04/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/30/2024

CNRT

NON-FINAL ACTION WRITTEN

10/29/2024

DOCK

ASSIGNED TO EXAMINER

10/17/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

08/10/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/15/2024

MAFR

APPLICATION FILING RECEIPT MAILED

05/14/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/14/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/09/2024

Continuous trademark protection

Get notified about every new filing that threatens ELORA. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.